MEDIFAST INC
corporate_fare Company Profile
MEDIFAST INC (NYSE:MED) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 23 items for MED at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Medifast Reports Steep Annual Revenue Decline and Net Loss for 2025, Citing GLP-1 Impact and Coach Network Contraction
- Medifast Reports Steep Revenue Decline, Net Loss, and Weak 2026 Outlook Amidst GLP-1 Headwinds
- Medifast Announces Planned CEO Transition and C-Suite Departure Amidst Leadership Reshuffle
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$385.79M
Net Income
-$18.67M
Diluted EPS
-$1.70
Op. Cash Flow
$6.86M
Free Cash Flow
$1.25M
Gross Profit
$275.19M
Operating Income
-$14.21M
Cash & Equivalents
$89.3M
Debt / Equity
0.00×
Net Margin
-4.8%
Shares Outstanding
10.99M sh
Source: 10-K · filed 2026-02-17 · accession 0001628280-26-008656
show_chartPrice Chart
Loading chart...
feed MED - Filings & News (Page 2)
MED
Feb 17, 2026, 4:54 PM EST
Price at Filing:
$10.40
Real-time Price:
$11.75
Change:
+$1.35 (+13%)
Market Cap:
$131.396M
MED
Feb 17, 2026, 4:44 PM EST
Price at Filing:
$10.40
Real-time Price:
$11.75
Change:
+$1.35 (+13%)
Market Cap:
$131.396M
MED
Jan 05, 2026, 9:02 AM EST
Price at Filing:
$10.40
Real-time Price:
$11.75
Change:
+$1.35 (+13%)
Market Cap:
$131.396M